AbbVie
ABBVAbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at AbbVie
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/16/2024 | Sell | Buckbee, Kevin K. | SVP, CONTROLLER | $172.2 | $310,032 |
| 8/5/2024 | Sell | Gonzalez, Richard A. | EXECUTIVE CHAIRMAN OF BOARD | $186.5 | $12,403,580 |
| 7/17/2024 | Sell | Gonzalez, Richard A. | EXECUTIVE CHAIRMAN OF BOARD | $175.0 | $49,497,875 |
| 3/20/2024 | Sell | Donoghoe, Nicholas | EVP, CHIEF BUS/STRAT OFFICER | $176.3 | $3,716,757 |
| 3/18/2024 | Sell | Stewart, Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | $178.9 | $10,539,509 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)